報價延遲最少15分鐘:2026/05/30 23:31 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.22 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.12/--
|
|
企業價值
248.62M
|
| 資產負債 |
|
每股賬面淨值
-0.04
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
596.82K
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue. |
